This list is based on the watchlists of people on Stock Events who follow KAPA. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
Show more...
FAQ
What is Kairos Pharma stock price today?▼
The current price of KAPA is $1.76 USD — it has increased by +5.49% in the past 24 hours. Watch Kairos Pharma stock price performance more closely on the chart.
What is Kairos Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Kairos Pharma stocks are traded under the ticker KAPA.
Is Kairos Pharma stock price growing?▼
KAPA stock has risen by +0.62% compared to the previous week, the month change is a -26.64% fall, over the last year Kairos Pharma has showed a -84.61% decrease.
What is Kairos Pharma market cap?▼
Today Kairos Pharma has the market capitalization of 5.65M
When is the next Kairos Pharma earnings date?▼
Kairos Pharma is going to release the next earnings report on December 02, 2026.
What is Kairos Pharma revenue for the last year?▼
Kairos Pharma revenue for the last year amounts to 0 USD.
What is Kairos Pharma net income for the last year?▼
KAPA net income for the last year is -5.45M USD.
How many employees does Kairos Pharma have?▼
As of September 04, 2026, the company has 1 employees.
In which sector is Kairos Pharma located?▼
Kairos Pharma operates in the Health & Wellness sector.
When did Kairos Pharma complete a stock split?▼
The last stock split for Kairos Pharma was on September 01, 2026 with a ratio of 1:7.
Where is Kairos Pharma headquartered?▼
Kairos Pharma is headquartered in LOS ANGELES, United States.